Mol2387 Posted - 2 days ago

$MNPR looking like gonna BK soon!

emrahkaya Posted - 3 days ago

$MNPR Bar has been raised to $2 https://markets.businessinsider.com/news/stocks/buy-rating-on-monopar-therapeutics-promising-trials-and-financial-stability-highlight-growth-potential-1033241677

MrGuttenburg Posted - 3 days ago

$MNPR https://www.abc4.com/business/press-releases/globenewswire/9091709/monopar-announces-radiopharma-presentation-selected-for-society-of-nuclear-medicine-and-molecular-imaging-2024-annual-meeting/

lecorb Posted - 1 week ago

$MNPR Short Interest 170.5K Short Interest % 3.32% Days to Cover 1 Float 5,131,142 04/09/2024 Benzinga

lecorb Posted - 1 week ago

$MNPR https://markets.businessinsider.com/news/stocks/buy-rating-on-monopar-therapeutics-promising-trials-and-financial-stability-highlight-growth-potential-1033241677

TheWushuWizard Posted - 1 week ago

$MNPR Hoping to break out of this bullish flag this afternoon or in the morning.

MrGuttenburg Posted - 1 week ago

$MNPR accumulating today. :)

Stock_Titan Posted - 1 week ago

$MNPR Monopar Announces Radiopharma Presentation Selected for Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting https://www.stocktitan.net/news/MNPR/monopar-announces-radiopharma-presentation-selected-for-society-of-c7zi88s3b3g7.html

Ugly1 Posted - 1 week ago

$MNPR new here. can someone share the bull case please?

emrahkaya Posted - 1 week ago

$MNPR. Awesome news! Waiting for the take off.. https://finance.yahoo.com/news/monopar-announces-filing-patent-protecting-120000017.html

Stock_Titan Posted - 1 week ago

$MNPR Monopar Announces Filing of Patent Protecting MNPR-101 Radiopharma Optimization Findings https://www.stocktitan.net/news/MNPR/monopar-announces-filing-of-patent-protecting-mnpr-101-radiopharma-gcsem8kgyxiq.html

emrahkaya Posted - 1 week ago

$MNPR nice build up.. this week a break out... ?

MrGuttenburg Posted - 1 week ago

$MNPR Positive vibes for Open tomorrow! $VINC

SadyK189 Posted - 2 weeks ago

My watch list result today: $YYAI closed at 1.09 yesterday. went till 1.57 today $CONN closed at 4.06 yesterday. went till 4.23 today $EGIO closed at 17.24 yesterday. went till 18.03 today $NKTR closed at 1.59 yesterday. went till 1.67 today $MNPR closed at 0.79 yesterday. went till 0.8150 today

SadyK189 Posted - 2 weeks ago

Top Stocks to watch tomorrow 3 / 3: $CONN $YYAI $EGIO $NKTR $MNPR

MrGuttenburg Posted - 2 weeks ago

$MNPR 😍

ANTHONYMOMO Posted - 2 weeks ago

$MNPR $2 on deck very thin float

WolfofFraudStreet Posted - 2 weeks ago

$MNPR Upgrade scare me more then downgrades!

emrahkaya Posted - 2 weeks ago

@braunthrax Indeed; but still i was surprised that my screener showed me this ticker…. Wait and see? Didn’t went all in tbh Im focusing on $MNPR

johnnyutah007 Posted - 2 weeks ago

$MNPR news 👀

lecorb Posted - 2 weeks ago

$MNPR April 11, 2024 8:48 am ET *Monopar Therapeutics shares are trading higher after JonesTrading upgraded the stock from Hold to Buy, Price Target is $2 Benzinga

emrahkaya Posted - 2 weeks ago

$MNPR Hop on

emrahkaya Posted - 2 weeks ago

$MNPR next in line! 🚀 🚀 I predicted $BSGM 💰

MrGuttenburg Posted - 2 weeks ago

$VINC let's get to 2. Please. Lol. In other news..$MNPR ..https://www.globenewswire.com/news-release/2024/04/10/2860708/0/en/Monopar-Initiates-Radiopharma-Phase-1-Clinical-Trial-for-MNPR-101-Zr-in-Advanced-Cancer-Patients.html

Stock_Titan Posted - 2 weeks ago

$MNPR Monopar Initiates Radiopharma Phase 1 Clinical Trial for MNPR-101-Zr in Advanced Cancer Patients https://www.stocktitan.net/news/MNPR/monopar-initiates-radiopharma-phase-1-clinical-trial-for-mnpr-101-zr-c925jdo02j4v.html

RallyRaider Posted - 2 weeks ago

$MNPR is a "revisit later"

toolajittooquit Posted - 3 weeks ago

$MNPR so what is the issue here. 1) product has toxicity issues, 2) results are misleading, 3) limited market for their drug, 4) problems raising money? Etc.

MrGuttenburg Posted - 3 weeks ago

$MNPR *sigh*

theflynews Posted - 03/28/24

Fly Intel: Pre-market Movers - $MNPR - https://thefly.com/permalinks/entry.php/MNPRid3889161

DonCorleone77 Posted - 03/28/24

$MNPR Monopar Therapeutics reports Q4 EPS (12c) vs (22c) last year Cash, cash equivalents and short-term investments as of December 31, 2023, were $7.3 million. Monopar expects that its current funds, which include an additional $3.2 million from the net proceeds of its at-the-market facility in Q1 2024, will be sufficient for Monopar to continue operations at least through June 30, 2025, to conduct and conclude its first-in-human clinical trial with Monopar's MNPR-101-Zr radiopharma program and continue the Company's other pipeline programs.